Table 5.
Symbol | Gene Name | Wt | Xpc-/- |
---|---|---|---|
1700003F12Rik | riken cdna 1700003f12 gene | 1.44 | 1.45 |
Atp7a | atpase, cu++ transporting, alpha polypeptide | 1.15 | 1.29 |
Bag1 | bcl2-associated athanogene 1 | 1.49 | 1.42 |
Bag4 | bcl2-associated athanogene 4 | -1.26 | -1.25 |
Brca2 | breast cancer 2 | -1.35 | -1.34 |
Cycs | cytochrome c, somatic | 1.21 | 1.37 |
Dap | death-associated protein | 1.31 | 1.25 |
Dhcr24 | 24-dehydrocholesterol reductase | 1.50 | 1.43 |
Dpf2 | d4, zinc and double phd fingers family 2 | 1.31 | 1.17 |
Faim | fas apoptotic inhibitory molecule | 1.21 | 1.20 |
Hells | helicase, lymphoid specific | 1.43 | 1.46 |
Hras1 | harvey rat sarcoma virus oncogene 1 | 1.20 | 1.15 |
Klrb1c | killer cell lectin-like receptor subfamily b member 1c | -1.09 | -1.18 |
Opa1 | optic atrophy 1 homolog (human) | -1.34 | -1.17 |
P2rx1 | purinergic receptor p2x, ligand-gated ion channel, 1 | 1.10 | 1.17 |
Pdcd5 | programmed cell death 5 | -1.22 | -1.23 |
Pim1 | proviral integration site 1 | -1.17 | -1.17 |
Proc | protein c | 1.26 | 1.22 |
Pten | phosphatase and tensin homolog | 1.32 | 1.31 |
Purb | purine rich element binding protein b | 1.16 | 1.30 |
Qars | glutaminyl-trna synthetase | 1.20 | 1.35 |
Rragc | ras-related gtp binding c | 1.29 | 1.25 |
Rybp | ring1 and yy1 binding protein | 1.18 | 1.37 |
Sh3 kbp1 | sh3-domain kinase binding protein 1 | -1.37 | -1.39 |
Smndc1 | survival motor neuron domain containing 1 | 1.21 | 1.35 |
Sra1 | steroid receptor rna activator 1 | 1.26 | 1.23 |
Sycp3 | synaptonemal complex protein 3 | 1.34 | 1.30 |
Tax1 bp1 | tax1 (human t-cell leukemia virus type i) binding protein 1 | 1.25 | 1.08 |
Tnfrsf4 | tumor necrosis factor receptor superfamily, member 4 | 1.30 | 1.11 |
Uaca | uveal autoantigen with coiled-coil domains and ankyrin repeats | 1.24 | 1.29 |
Uaca | uveal autoantigen with coiled-coil domains and ankyrin repeats | 1.14 | 1.21 |
Zdhhc16 | zinc finger, dhhc domain containing 16 | 1.25 | 1.36 |
32 differentially regulated genes concerning apoptosis. Results are presented as average gene expression ratios between exposed and control samples.